Multidimensional Characterisation of RNA-Based Vaccines & Therapies
Time: 2:30 pm
day: Day 1 Track 1 PM
Details:
- Evaluate potency through the identification of ribosome stalls that reduce protein production
- Examine purity by discovering the sequences and structures that lead to dsRNA by-products
- Measure safety through studies of off-target changes in transcription and translation
